Hugel Receives U.S. FDA Approval for Its Botulinum Toxin Letybo

Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic markets – U.S., Europe and China U.S. is the largest and fastest growing aesthetic market globally at USD 2.5 bn in 2023, and expected to nearly double to USD 4.9 bn by 2031 SEOUL,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.